Vault-13

Siren, L.L.C.

New York, NY · CIK 2005245 · 13F filing filed 2025-08-13

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$1.9bn reported value +9.0% vs Q1 2025
110positions
48.5%in top 10
15 new 21 added 19 reduced 21 sold out vs Q1 2025

This report includes the holdings of 2 other managers that share the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 9,250,005 $327.6m16.95% 16.95% UnchangedShares held: Q3 2024 11.3m, Q4 2024 9.3m, Q1 2025 9.3m, Q2 2025 9.3m
2 KYMERA THERAPEUTICS INC COM KYMR KYMR 3,428,150 $149.6m7.74% 7.74% AddedShares held: Q3 2024 3.0m, Q4 2024 3.0m, Q1 2025 3.2m, Q2 2025 3.4m +187.8k +187,837 5.8%
3 BEIGENE LTD SPONSORED ADR ONC ONC 509,990 $123.5m6.39% 6.39% AddedShares held: Q3 2024 563.3k, Q4 2024 653.7k, Q1 2025 498.7k, Q2 2025 510.0k +11.3k +11,301 2.3%
4 DISC MEDICINE INC COM IRON IRON 1,099,401 $58.2m3.01% 3.01% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 1.1m, Q2 2025 1.1m +27.5k +27,536 2.6%
5 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 1,688,611 $48.6m2.51% 2.51% UnchangedShares held: Q3 2024 1.3m, Q4 2024 1.6m, Q1 2025 1.7m, Q2 2025 1.7m
6 BICARA THERAPEUTICS INC COM BCAX BCAX 5,216,969 $48.5m2.51% 2.51% AddedShares held: Q3 2024 3.1m, Q4 2024 3.3m, Q1 2025 3.3m, Q2 2025 5.2m +1.9m +1,949,886 59.7%
7 DYNE THERAPEUTICS INC COM DYN DYN 4,836,437 $46.0m2.38% 2.38% AddedShares held: Q3 2024 1.1m, Q4 2024 1.3m, Q1 2025 2.7m, Q2 2025 4.8m +2.1m +2,118,450 77.9%
8 CENTESSA PHARMACEUTICALS PLC SPONSORED ADS SPONSORED ADS 3,460,029 $45.5m2.35% 2.35% AddedShares held: Q3 2024 3.3m, Q4 2024 3.0m, Q1 2025 3.0m, Q2 2025 3.5m +500.0k +500,000 16.9%
9 MERUS N V COM MRUS MRUS 853,467 $44.9m2.32% 2.32% ReducedShares held: Q3 2024 682.2k, Q4 2024 784.4k, Q1 2025 1.0m, Q2 2025 853.5k -190.0k -190,000 -18.2%
10 APELLIS PHARMACEUTICALS INC COM APLS APLS 2,578,396 $44.6m2.31% 2.31% UnchangedShares held: Q3 2024 2.2m, Q4 2024 2.8m, Q1 2025 2.6m, Q2 2025 2.6m
11 ASCENDIS PHARMA A/S SPONSORED ADR SPONSORED ADR 245,943 $42.4m2.20% 2.20% ReducedShares held: Q3 2024 347.9k, Q4 2024 297.3k, Q1 2025 287.4k, Q2 2025 245.9k -41.4k -41,423 -14.4%
12 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 2,669,880 $42.2m2.18% 2.18% UnchangedShares held: Q3 2024 2.5m, Q4 2024 2.9m, Q1 2025 2.7m, Q2 2025 2.7m
13 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 3,160,298 $41.4m2.14% 2.14% AddedShares held: Q3 2024 404.1k, Q4 2024 734.3k, Q1 2025 1.7m, Q2 2025 3.2m +1.5m +1,463,854 86.3%
14 SOLENO THERAPEUTICS INC COM SLNO SLNO 467,342 $39.2m2.03% 2.03% ReducedShares held: Q3 2024 0, Q4 2024 351.8k, Q1 2025 727.3k, Q2 2025 467.3k -260.0k -259,995 -35.8%
15 LEXICON PHARMACEUTICALS INC COM NEW LXRX LXRX 38,918,903 $36.8m1.90% 1.90% UnchangedShares held: Q3 2024 38.9m, Q4 2024 38.9m, Q1 2025 38.9m, Q2 2025 38.9m
16 TABOOLA.COM LTD ORD SHS TBLA TBLA 9,969,495 $36.5m1.89% 1.89% UnchangedShares held: Q3 2024 10.0m, Q4 2024 10.0m, Q1 2025 10.0m, Q2 2025 10.0m
17 SOLID BIOSCIENCES INC COM NEW SLDB SLDB 7,415,905 $36.1m1.87% 1.87% UnchangedShares held: Q3 2024 2.7m, Q4 2024 3.7m, Q1 2025 7.4m, Q2 2025 7.4m
18 REVOLUTION MEDICINES INC COM RVMD RVMD 938,755 $34.5m1.79% 1.79% AddedShares held: Q3 2024 753.6k, Q4 2024 571.5k, Q1 2025 563.8k, Q2 2025 938.8k +375.0k +375,000 66.5%
19 AVIDITY BIOSCIENCES INC COM RNA RNA 1,110,610 $31.5m1.63% 1.63% UnchangedShares held: Q3 2024 1.4m, Q4 2024 1.1m, Q1 2025 1.1m, Q2 2025 1.1m
20 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 409,742 $25.9m1.34% 1.34% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 277.5k, Q2 2025 409.7k +132.2k +132,209 47.6%
21 APOGEE THERAPEUTICS INC COM COM 594,994 $25.8m1.34% 1.34% UnchangedShares held: Q3 2024 0, Q4 2024 747.3k, Q1 2025 595.0k, Q2 2025 595.0k
22 STOKE THERAPEUTICS INC COM STOK STOK 2,247,347 $25.5m1.32% 1.32% UnchangedShares held: Q3 2024 0, Q4 2024 2.0m, Q1 2025 2.2m, Q2 2025 2.2m
23 TAYSHA GENE THERAPIES INC COM SHS TSHA TSHA 11,014,737 $25.4m1.32% 1.32% AddedShares held: Q3 2024 4.9m, Q4 2024 6.6m, Q1 2025 6.5m, Q2 2025 11.0m +4.5m +4,500,000 69.1%
24 XENON PHARMACEUTICALS INC COM XENE XENE 812,761 $25.4m1.32% 1.32% AddedShares held: Q3 2024 743.8k, Q4 2024 743.8k, Q1 2025 732.8k, Q2 2025 812.8k +80.0k +80,000 10.9%
25 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 3,696,322 $24.0m1.24% 1.24% UnchangedShares held: Q3 2024 5.7m, Q4 2024 3.8m, Q1 2025 3.7m, Q2 2025 3.7m
26 MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD MLTX MLTX 508,267 $24.0m1.24% 1.24% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 508.3k
27 SEPTERNA INC COM SEPN SEPN 2,202,514 $23.3m1.20% 1.20% UnchangedShares held: Q3 2024 0, Q4 2024 2.2m, Q1 2025 2.2m, Q2 2025 2.2m
28 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 1,194,240 $21.6m1.12% 1.12% ReducedShares held: Q3 2024 920.6k, Q4 2024 2.1m, Q1 2025 1.9m, Q2 2025 1.2m -717.8k -717,790 -37.5%
29 TREVI THERAPEUTICS INC COM TRVI TRVI 3,938,793 $21.5m1.11% 1.11% AddedShares held: Q3 2024 0, Q4 2024 2.9m, Q1 2025 2.9m, Q2 2025 3.9m +1.1m +1,075,000 37.5%
30 TANGO THERAPEUTICS INC COM TNGX TNGX 3,364,814 $17.2m0.89% 0.89% AddedShares held: Q3 2024 2.6m, Q4 2024 2.6m, Q1 2025 2.6m, Q2 2025 3.4m +799.5k +799,472 31.2%
31 AKERO THERAPEUTICS INC COM AKRO AKRO 318,647 $17.0m0.88% 0.88% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 318.6k
32 SILENCE THERAPEUTICS PLC ADS SLN SLN 2,911,438 $16.9m0.87% 0.87% AddedShares held: Q3 2024 2.8m, Q4 2024 2.8m, Q1 2025 2.8m, Q2 2025 2.9m +121.6k +121,605 4.4%
33 ARRIVENT BIOPHARMA INC COM AVBP AVBP 700,000 $15.2m0.79% 0.79% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 700.0k
34 BICYCLE THERAPEUTICS PLC SPONSORED ADS BCYC BCYC 2,012,752 $14.0m0.72% 0.72% AddedShares held: Q3 2024 0, Q4 2024 1.8m, Q1 2025 1.8m, Q2 2025 2.0m +200.0k +200,000 11.0%
35 ARCUS BIOSCIENCES INC COM RCUS RCUS 1,612,077 $13.1m0.68% 0.68% UnchangedShares held: Q3 2024 1.6m, Q4 2024 1.6m, Q1 2025 1.6m, Q2 2025 1.6m
36 IHS HOLDING LIMITED ORD SHS IHS IHS 2,357,520 $13.1m0.68% 0.68% UnchangedShares held: Q3 2024 2.4m, Q4 2024 2.4m, Q1 2025 2.4m, Q2 2025 2.4m
37 AMAZON COM INC COM AMZN AMZN 56,500 $12.4m0.64% 0.64% UnchangedShares held: Q3 2024 34.8k, Q4 2024 36.5k, Q1 2025 56.5k, Q2 2025 56.5k
38 DENALI THERAPEUTICS INC COM DNLI DNLI 821,513 $11.5m0.59% 0.59% UnchangedShares held: Q3 2024 834.0k, Q4 2024 834.0k, Q1 2025 821.5k, Q2 2025 821.5k
39 ERASCA INC COM ERAS ERAS 8,757,249 $11.1m0.58% 0.58% UnchangedShares held: Q3 2024 8.9m, Q4 2024 8.9m, Q1 2025 8.8m, Q2 2025 8.8m
40 ORIC PHARMACEUTICALS INC COM ORIC ORIC 1,007,575 $10.2m0.53% 0.53% UnchangedShares held: Q3 2024 1.0m, Q4 2024 1.0m, Q1 2025 1.0m, Q2 2025 1.0m
41 REMITLY GLOBAL INC COM RELY RELY 515,449 $9.7m0.50% 0.50% AddedShares held: Q3 2024 25.0k, Q4 2024 490.4k, Q1 2025 490.4k, Q2 2025 515.4k +25.0k +25,000 5.1%
42 VAXCYTE INC COM PCVX PCVX 295,543 $9.6m0.50% 0.50% UnchangedShares held: Q3 2024 300.0k, Q4 2024 300.0k, Q1 2025 295.5k, Q2 2025 295.5k
43 CROWDSTRIKE HLDGS INC CL A CRWD CRWD 18,500 $9.4m0.49% 0.49% ReducedShares held: Q3 2024 25.0k, Q4 2024 24.0k, Q1 2025 25.0k, Q2 2025 18.5k -6.5k -6,500 -26.0%
44 CULLINAN THERAPEUTICS INC COM CGEM CGEM 1,193,410 $9.0m0.47% 0.47% UnchangedShares held: Q3 2024 1.2m, Q4 2024 1.2m, Q1 2025 1.2m, Q2 2025 1.2m
45 ALPHABET INC CAP STK CL A GOOGL GOOGL 50,703 $8.9m0.46% 0.46% UnchangedShares held: Q3 2024 11.0k, Q4 2024 7.0k, Q1 2025 50.7k, Q2 2025 50.7k
46 UPSTREAM BIO INC COM UPB UPB 788,450 $8.7m0.45% 0.45% UnchangedShares held: Q3 2024 0, Q4 2024 800.0k, Q1 2025 788.5k, Q2 2025 788.5k
47 SEER INC COM CL A SEER SEER 4,000,000 $8.6m0.44% 0.44% UnchangedShares held: Q3 2024 4.0m, Q4 2024 4.0m, Q1 2025 4.0m, Q2 2025 4.0m
48 MICROSOFT CORP COM MSFT MSFT 16,150 $8.0m0.42% 0.42% ReducedShares held: Q3 2024 22.0k, Q4 2024 23.0k, Q1 2025 28.5k, Q2 2025 16.1k -12.3k -12,350 -43.3%
49 NVIDIA CORPORATION COM NVDA NVDA 49,985 $7.9m0.41% 0.41% AddedShares held: Q3 2024 48.9k, Q4 2024 48.9k, Q1 2025 44.4k, Q2 2025 50.0k +5.6k +5,553 12.5%
50 IONQ INC COM IONQ IONQ 170,000 $7.3m0.38% 0.38% UnchangedShares held: Q3 2024 500.0k, Q4 2024 170.0k, Q1 2025 170.0k, Q2 2025 170.0k
51 TAIWAN SEMICONDUCTOR MFG LTD SPONSORED ADS TSM TSM 30,500 $6.9m0.36% 0.36% AddedShares held: Q3 2024 25.0k, Q4 2024 15.0k, Q1 2025 28.5k, Q2 2025 30.5k +2.0k +2,000 7.0%
52 GOSSAMER BIO INC COM GOSS GOSS 5,208,968 $6.4m0.33% 0.33% UnchangedShares held: Q3 2024 13.3m, Q4 2024 5.2m, Q1 2025 5.2m, Q2 2025 5.2m
53 SALESFORCE INC COM CRM CRM 22,600 $6.2m0.32% 0.32% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 14.6k, Q2 2025 22.6k +8.0k +8,000 54.8%
54 COGENT BIOSCIENCES INC COM COGT COGT 854,379 $6.1m0.32% 0.32% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 854.4k
55 CARTESIAN THERAPEUTICS INC COM NEW RNAC RNAC 563,272 $5.9m0.30% 0.30% UnchangedShares held: Q3 2024 572.2k, Q4 2024 572.2k, Q1 2025 563.3k, Q2 2025 563.3k
56 VERA THERAPEUTICS INC CL A VERA VERA 247,216 $5.8m0.30% 0.30% ReducedShares held: Q3 2024 837.9k, Q4 2024 758.5k, Q1 2025 747.2k, Q2 2025 247.2k -500.0k -500,000 -66.9%
57 ADOBE INC COM ADBE ADBE 15,051 $5.8m0.30% 0.30% ReducedShares held: Q3 2024 1.0k, Q4 2024 8.8k, Q1 2025 19.3k, Q2 2025 15.1k -4.2k -4,247 -22.0%
58 SIONNA THERAPEUTICS INC COM SION SION 325,000 $5.6m0.29% 0.29% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 325.0k, Q2 2025 325.0k
59 PDD HOLDINGS INC SPONSORED ADS PDD PDD 52,901 $5.5m0.29% 0.29% UnchangedShares held: Q3 2024 40.4k, Q4 2024 52.9k, Q1 2025 52.9k, Q2 2025 52.9k
60 SAGIMET BIOSCIENCES INC COM SER A SGMT SGMT 724,771 $5.5m0.29% 0.29% UnchangedShares held: Q3 2024 724.8k, Q4 2024 724.8k, Q1 2025 724.8k, Q2 2025 724.8k
61 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 368,598 $5.5m0.29% 0.29% UnchangedShares held: Q3 2024 0, Q4 2024 374.0k, Q1 2025 368.6k, Q2 2025 368.6k
62 PACIRA BIOSCIENCES INC COM PCRX PCRX 225,000 $5.4m0.28% 0.28% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 225.0k
63 SERVICENOW INC COM NOW NOW 5,126 $5.3m0.27% 0.27% ReducedShares held: Q3 2024 7.5k, Q4 2024 5.6k, Q1 2025 9.1k, Q2 2025 5.1k -4.0k -4,000 -43.8%
64 KORRO BIO INC COM KRRO KRRO 418,833 $5.2m0.27% 0.27% UnchangedShares held: Q3 2024 418.8k, Q4 2024 418.8k, Q1 2025 418.8k, Q2 2025 418.8k
65 DATADOG INC CL A COM DDOG DDOG 38,425 $5.2m0.27% 0.27% ReducedShares held: Q3 2024 32.9k, Q4 2024 30.4k, Q1 2025 47.4k, Q2 2025 38.4k -9.0k -9,000 -19.0%
66 AGENUS INC COM NEW AGEN AGEN 1,064,250 $4.9m0.25% 0.25% AddedShares held: Q3 2024 775.0k, Q4 2024 0, Q1 2025 500.0k, Q2 2025 1.1m +564.2k +564,250 112.8%
67 JFROG LTD ORD SHS FROG FROG 107,116 $4.7m0.24% 0.24% ReducedShares held: Q3 2024 61.0k, Q4 2024 120.1k, Q1 2025 131.6k, Q2 2025 107.1k -24.5k -24,500 -18.6%
68 RAPPORT THERAPEUTICS INC COM RAPP RAPP 378,469 $4.3m0.22% 0.22% UnchangedShares held: Q3 2024 384.2k, Q4 2024 384.2k, Q1 2025 378.5k, Q2 2025 378.5k
69 INSTIL BIO INC COM NEW TIL TIL 203,933 $4.2m0.22% 0.22% UnchangedShares held: Q3 2024 192.4k, Q4 2024 192.4k, Q1 2025 203.9k, Q2 2025 203.9k
70 DYNATRACE INC COM NEW DT DT 75,229 $4.2m0.21% 0.21% ReducedShares held: Q3 2024 82.7k, Q4 2024 82.7k, Q1 2025 87.7k, Q2 2025 75.2k -12.5k -12,500 -14.2%
71 AADI BIOSCIENCE INC COM WHWK WHWK 2,082,000 $3.9m0.20% 0.20% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 2.1m, Q2 2025 2.1m
72 NEW ORIENTAL ED & TECHNOLOGY SPON ADR EDU EDU 72,000 $3.9m0.20% 0.20% ReducedShares held: Q3 2024 38.5k, Q4 2024 68.5k, Q1 2025 79.5k, Q2 2025 72.0k -7.5k -7,500 -9.4%
73 IGM BIOSCIENCES INC COM IGMS IGMS 3,255,826 $3.6m0.19% 0.19% UnchangedShares held: Q3 2024 3.3m, Q4 2024 3.3m, Q1 2025 3.3m, Q2 2025 3.3m
74 FOGHORN THERAPEUTICS INC COM FHTX FHTX 720,720 $3.4m0.18% 0.18% UnchangedShares held: Q3 2024 720.7k, Q4 2024 720.7k, Q1 2025 720.7k, Q2 2025 720.7k
75 VIGIL NEUROSCIENCE INC COM VIGL VIGL 411,191 $3.3m0.17% 0.17% ReducedShares held: Q3 2024 2.0m, Q4 2024 2.0m, Q1 2025 2.0m, Q2 2025 411.2k -1.6m -1,555,873 -79.1%
76 NEUMORA THERAPEUTICS INC. COM NMRA NMRA 4,358,283 $3.2m0.17% 0.17% UnchangedShares held: Q3 2024 2.6m, Q4 2024 4.4m, Q1 2025 4.4m, Q2 2025 4.4m
77 PROQR THRAPEUTICS N V SHS EURO PRQR PRQR 1,552,183 $3.2m0.16% 0.16% UnchangedShares held: Q3 2024 0, Q4 2024 1.6m, Q1 2025 1.6m, Q2 2025 1.6m
78 NEBIUS GROUP N.V. SHS CLASS A NBIS NBIS 51,000 $2.8m0.15% 0.15% ReducedShares held: Q3 2024 0, Q4 2024 120.0k, Q1 2025 140.0k, Q2 2025 51.0k -89.0k -89,000 -63.6%
79 BLACK DIAMOND THERAPEUTICS I COM BDTX BDTX 1,046,517 $2.6m0.13% 0.13% UnchangedShares held: Q3 2024 1.0m, Q4 2024 1.0m, Q1 2025 1.0m, Q2 2025 1.0m
80 LEXEO THERAPEUTICS INC COM LXEO LXEO 603,435 $2.4m0.13% 0.13% UnchangedShares held: Q3 2024 603.4k, Q4 2024 603.4k, Q1 2025 603.4k, Q2 2025 603.4k
81 PALO ALTO NETWORKS INC COM PANW PANW 11,500 $2.4m0.12% 0.12% UnchangedShares held: Q3 2024 9.0k, Q4 2024 6.0k, Q1 2025 11.5k, Q2 2025 11.5k
82 QUALCOMM INC COM QCOM QCOM 14,000 $2.2m0.12% 0.12% UnchangedShares held: Q3 2024 15.0k, Q4 2024 15.0k, Q1 2025 14.0k, Q2 2025 14.0k
83 WORKIVA INC COM CL A WK WK 28,000 $1.9m0.10% 0.10% AddedShares held: Q3 2024 0, Q4 2024 10.0k, Q1 2025 17.5k, Q2 2025 28.0k +10.5k +10,500 60.0%
84 ELEDON PHARMACEUTICALS INC COM ELDN ELDN 690,170 $1.9m0.10% 0.10% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 690.2k, Q2 2025 690.2k
85 KE HLDGS INC SPONSORED ADS BEKE BEKE 105,000 $1.9m0.10% 0.10% UnchangedShares held: Q3 2024 100.0k, Q4 2024 60.0k, Q1 2025 105.0k, Q2 2025 105.0k
86 HUBSPOT INC COM HUBS HUBS 3,000 $1.7m0.09% 0.09% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 3.0k
87 UNITEDHEALTH GROUP INC COM UNH UNH 5,076 $1.6m0.08% 0.08% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 5.1k
88 BIOAGE LABS INC COM BIOA BIOA 382,406 $1.6m0.08% 0.08% UnchangedShares held: Q3 2024 300.0k, Q4 2024 388.0k, Q1 2025 382.4k, Q2 2025 382.4k
89 GITLAB INC CLASS A COM GTLB GTLB 35,000 $1.6m0.08% 0.08% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 35.0k
90 TOURMALINE BIO INC COM TRML TRML 91,426 $1.5m0.08% 0.08% UnchangedShares held: Q3 2024 91.4k, Q4 2024 91.4k, Q1 2025 91.4k, Q2 2025 91.4k
91 ROCKET PHARMACEUTICALS INC COM RCKT RCKT 591,263 $1.4m0.07% 0.07% UnchangedShares held: Q3 2024 0, Q4 2024 600.0k, Q1 2025 591.3k, Q2 2025 591.3k
92 TESLA INC COM TSLA TSLA 4,000 $1.3m0.07% 0.07% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 9.0k, Q2 2025 4.0k -5.0k -5,000 -55.6%
93 BIRKENSTOCK HOLDING PLC COM SHS BIRK BIRK 25,000 $1.2m0.06% 0.06% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 25.0k
94 SAILPOINT INC COM SAIL SAIL 50,000 $1.1m0.06% 0.06% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 95.0k, Q2 2025 50.0k -45.0k -45,000 -47.4%
95 SEMRUSH HLDGS INC CL A COM SEMR SEMR 125,000 $1.1m0.06% 0.06% UnchangedShares held: Q3 2024 0, Q4 2024 35.0k, Q1 2025 125.0k, Q2 2025 125.0k
96 PRIMO BRANDS CORPORATION CLASS A COM SHS PRMB PRMB 37,500 $1.1m0.06% 0.06% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 37.5k
97 CELLEBRITE DI LTD ORDINARY SHARES CLBT CLBT 60,000 $960.0k0.05% 0.05% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 60.0k
98 GENERATION BIO CO COM COM 2,968,925 $950.4k0.05% 0.05% UnchangedShares held: Q3 2024 3.0m, Q4 2024 3.0m, Q1 2025 3.0m, Q2 2025 3.0m
99 KALARIS THERAPEUTICS INC COM KLRS KLRS 282,586 $754.5k0.04% 0.04% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 282.6k, Q2 2025 282.6k
100 HOOKIPA PHARMA INC COM NEW COM NEW 566,640 $711.1k0.04% 0.04% UnchangedShares held: Q3 2024 566.6k, Q4 2024 566.6k, Q1 2025 566.6k, Q2 2025 566.6k

Sold out since Q1 2025

SecurityTickerShares held beforeValue then
BLUEPRINT MEDICINES CORP BPMC BPMC 726,167 $64.3m726.2k shares
PROTHENA CORP PLC PRTA PRTA 1,283,555 $15.9m1.3m shares
SUMMIT THERAPEUTICS INC SMMT SMMT 695,000 $13.4m695.0k shares
METSERA INC 150,000 $4.1m150.0k shares
LPL FINL HLDGS INC LPLA LPLA 7,500 $2.5m7.5k shares
MARVELL TECHNOLOGY INC MRVL MRVL 36,808 $2.3m36.8k shares
STANDARDAERO INC SARO SARO 56,855 $1.5m56.9k shares
BILL HOLDINGS INC BILL BILL 28,500 $1.3m28.5k shares
PAYPAL HLDGS INC PYPL PYPL 20,000 $1.3m20.0k shares
PEGASYSTEMS INC PEGA PEGA 16,500 $1.1m16.5k shares
MONGODB INC MDB MDB 5,500 $964.7k5.5k shares
NIKE INC NKE NKE 15,000 $952.2k15.0k shares
INTEL CORP INTC INTC 40,000 $908.4k40.0k shares
INFORMATICA INC INFA INFA 50,000 $872.5k50.0k shares
BOEING CO BA BA 5,000 $852.8k5.0k shares
COUCHBASE INC BASE BASE 49,850 $785.1k49.9k shares
KRONOS BIO INC KRON KRON 842,954 $695.4k843.0k shares
FERRARI N V RACE RACE 1,500 $636.4k1.5k shares
US BANCORP DEL USB USB 12,500 $527.8k12.5k shares
OCCIDENTAL PETE CORP OXY OXY 10,000 $493.6k10.0k shares
GDS HLDGS LTD GDS GDS 12,500 $316.6k12.5k shares